ARALEZ PHARMACEUTICALS INC - COM (ARLZ)

CUSIP: 03852X100

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
15,890,827
Share change
-7,408,899
Total reported value
$21,452,004
Put/Call ratio
135%
Price per share
$1.35
Number of holders
55
Value change
-$13,230,322
Number of buys
25
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q2 2017

As of 30 Jun 2017, ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,890,827 shares. The largest 10 holders included PAR CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, DEERFIELD MANAGEMENT CO, BlackRock Inc., DEUTSCHE BANK AG\, GSA CAPITAL PARTNERS LLP, JW Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, FMR LLC, and Contrarius Investment Management Ltd. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.